Select Medical is a healthcare company based in Pennsylvania. It owns long-term acute care and inpatient rehabilitation hospitals, as well as occupational health and physical therapy clinics. Select Medical is a subsidiary of Select Medical Holdings, which is listed on the New York Stock Exchange.
| trading_symbol | registrant_name | time | price | change | percentage_change |
|---|---|---|---|---|---|
| SEM | SELECT MEDICAL HOLDINGS CORP | 2026-03-03 12:06:23 | 16.25 | 1.25 | 8.33 |
| trading_symbol | central_index_key | registrant_name | isin_number | lei_number | ein_number | exchange | sic_code | sic_description | fiscal_year_end | state_of_incorporation | address_street | address_city | address_state | address_zip_code | address_country | address_country_code | phone_number | mailing_address | business_address | former_name | industry | founding_date | chief_executive_officer | number_of_employees | website | market_cap | shares_issued | shares_outstanding | description | update_time |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| SEM | 0001320414 | SELECT MEDICAL HOLDINGS CORP | US81619Q1058 | — | — | NYSE | 8060 | Services-Hospitals | 1231 | — | C/O SELECT MEDICAL CORP | MECHANICSBURG | PA | 17055 | UNITED STATES | US | 717-972-1100 | C/O SELECT MEDICAL CORP, MECHANICSBURG, PA, 17055 | C/O SELECT MEDICAL CORP, MECHANICSBURG, PA, 17055 | — | Healthcare | 1996 | David Chernow | 47,596 | http://www.selectmedical.com | 1,558,171,836 | 124,017,191 | 124,017,191 | Select Medical is a healthcare company based in Pennsylvania. It owns long-term acute care and inpatient rehabilitation hospitals, as well as occupational health and physical therapy clinics. Select Medical is a subsidiary of Select Medical Holdings, which is listed on the New York Stock Exchange. | 2026-02-26 17:30:41 |
| Fiscal Year | Market Cap | Change In Market Cap | Percentage Change In Market Cap | Shares Outstanding | Change In Shares Outstanding | Percentage Change In Shares Outstanding |
|---|---|---|---|---|---|---|
| 2025 | 1,558,171,836 | -2,064,447,926 | -56.9877 | 124,017,191 | -4,945,659 | -3.8349 |
| 2024 | 3,622,619,762 | 368,957,406 | 11.3398 | 128,962,850 | 601,358 | 0.4685 |
| 2023 | 3,253,662,356 | 892,388,931 | 37.7927 | 128,361,492 | 1,187,621 | 0.9339 |
| Executive Name | Executive Position | Fiscal Year | Salary | Bonus | Stock Awards | Incentive Plan Compensation | Other Compensation | Total Compensation |
|---|---|---|---|---|---|---|---|---|
| Michael F. Malatesta | Chief Financial Officer, Executive Vice President | 2023 | 534,363 | 377,979 | 564,000 | 0 | 49,902 | 1,526,244 |
| Martin F. Jackson | Chief Financial Officer, Executive Vice President | 2022 | 700,000 | — | 4,456,500 | 0 | 218,891 | 5,375,391 |
| David S. Chernow | Chief Executive Officer, President | 2022 | 995,000 | — | 7,427,500 | 0 | 357,979 | 8,780,479 |
| Robert A. Ortenzio | Executive Chairman, Co-Founder | 2022 | 995,000 | — | 7,427,500 | 0 | 415,825 | 8,838,325 |
| Rocco A. Ortenzio | Co-Founder, Vice Chairman | 2022 | 950,000 | — | 4,456,500 | 0 | 213,130 | 5,619,630 |
| Fiscal Year | Employee Count |
|---|---|
| 2025 | 45,300 |
| 2024 | 44,100 |
| 2023 | 54,600 |
| Fiscal Year | 2025 | 2024 | 2023 |
|---|---|---|---|
| Revenue | 5,452,830,000 | 5,187,105,000 | 6,664,058,000 |
| Cost Of Revenue | 4,823,535,000 | 4,553,461,000 | 5,732,017,000 |
| Gross Profit | — | — | — |
| Research And Development Expenses | — | — | — |
| General And Administrative Expenses | 154,414,000 | 225,869,000 | 170,193,000 |
| Operating Expenses | 5,118,252,000 | 4,922,196,000 | 6,110,952,000 |
| Operating Income | 336,170,000 | 268,315,000 | 554,874,000 |
| Net Income | 146,219,000 | 214,038,000 | 243,491,000 |
| Earnings Per Share Basic | 1.16 | 1.66 | 1.91 |
| Earnings Per Share Diluted | 1.16 | 1.66 | 1.91 |
| Weighted Average Shares Outstanding Basic | 122,647,000 | 124,614,000 | 123,105,000 |
| Weighted Average Shares Outstanding Diluted | 122,647,000 | 124,614,000 | 123,105,000 |
| Fiscal Year | 2025 | 2024 | 2023 |
|---|---|---|---|
| Cash And Cash Equivalents | 26,523,000 | 59,694,000 | 84,006,000 |
| Marketable Securities Current | — | — | — |
| Accounts Receivable | 864,207,000 | 821,385,000 | 940,335,000 |
| Inventories | — | — | — |
| Non Trade Receivables | — | — | — |
| Other Assets Current | 114,929,000 | 112,097,000 | 151,617,000 |
| Total Assets Current | 1,025,281,000 | 1,019,777,000 | 1,257,646,000 |
| Marketable Securities Non Current | — | — | — |
| Property Plant And Equipment | — | — | 1,023,561,000 |
| Other Assets Non Current | 414,388,000 | 372,813,000 | 376,722,000 |
| Total Assets Non Current | 573,771,000 | 522,412,000 | 523,762,000 |
| Total Assets | 5,851,589,000 | 5,607,951,000 | 7,689,631,000 |
| Accounts Payable | 157,063,000 | 142,157,000 | 174,312,000 |
| Deferred Revenue | — | — | — |
| Short Term Debt | 24,217,000 | 20,269,000 | 70,329,000 |
| Other Liabilities Current | 57,900,000 | 59,000,000 | 161,800,000 |
| Total Liabilities Current | 984,494,000 | 977,651,000 | 1,248,465,000 |
| Long Term Debt | 1,803,979,000 | 1,691,546,000 | 3,587,675,000 |
| Other Liabilities Non Current | 79,858,000 | 73,038,000 | 110,303,000 |
| Total Liabilities Non Current | 217,253,000 | 213,345,000 | 225,209,000 |
| Total Liabilities | 3,815,850,000 | 3,610,856,000 | 6,115,616,000 |
| Common Stock | 124,000 | 129,000 | 128,000 |
| Retained Earnings | 837,016,000 | 770,146,000 | 751,856,000 |
| Accumulated Other Comprehensive Income | -6,404,000 | 0 | 42,907,000 |
| Total Shareholders Equity | 1,705,584,000 | 1,681,355,000 | 1,288,304,000 |
| Fiscal Year | 2025 | 2024 | 2023 |
|---|---|---|---|
| Depreciation And Amortization | 140,303,000 | 203,894,000 | 208,742,000 |
| Share Based Compensation Expense | 16,702,000 | 100,670,000 | 43,809,000 |
| Other Non Cash Income Expense | — | — | — |
| Change In Accounts Receivable | 45,185,000 | 95,845,000 | -1,156,000 |
| Change In Inventories | — | — | — |
| Change In Non Trade Receivables | — | — | — |
| Change In Other Assets | — | — | — |
| Change In Accounts Payable | -854,000 | -16,789,000 | -6,412,000 |
| Change In Other Liabilities | -5,244,000 | 26,492,000 | 84,095,000 |
| Cash From Operating Activities | 346,467,000 | 517,864,000 | 582,058,000 |
| Purchases Of Marketable Securities | — | — | — |
| Sales Of Marketable Securities | — | — | — |
| Acquisition Of Property Plant And Equipment | 229,225,000 | 222,177,000 | 229,200,000 |
| Acquisition Of Business | 9,197,000 | 13,097,000 | 29,567,000 |
| Other Investing Activities | — | — | — |
| Cash From Investing Activities | -216,486,000 | -231,011,000 | -268,477,000 |
| Tax Withholding For Share Based Compensation | — | — | — |
| Payments Of Dividends | 31,435,000 | 64,617,000 | 63,904,000 |
| Issuance Of Common Stock | — | — | — |
| Repurchase Of Common Stock | — | — | — |
| Issuance Of Long Term Debt | 0 | 1,176,598,000 | — |
| Repayment Of Long Term Debt | — | — | — |
| Other Financing Activities | — | — | — |
| Cash From Financing Activities | -163,152,000 | -311,165,000 | -327,481,000 |
| Change In Cash | -33,171,000 | -24,312,000 | -13,900,000 |
| Cash At End Of Period | 26,523,000 | 59,694,000 | 84,006,000 |
| Income Taxes Paid | 26,022,000 | 133,187,000 | 88,510,000 |
| Interest Paid | 120,624,000 | 256,229,000 | 272,261,000 |
| Fiscal Year | 2025 | 2024 | 2023 |
|---|---|---|---|
| Earnings Per Share | 1.16 | 1.66 | 1.91 |
| Price To Earnings Ratio | 12.8017 | 11.3554 | 6.4697 |
| Earnings Growth Rate | -30.1205 | -13.089 | 55.2846 |
| Price Earnings To Growth Ratio | -0.425 | -0.8676 | 0.117 |
| Book Value Per Share | 16.5984 | 16.0262 | 12.786 |
| Price To Book Ratio | 0.8947 | 1.1762 | 0.9665 |
| Ebitda | 430,486,000 | 679,724,000 | 739,382,000 |
| Enterprise Value | 3,622,980,950 | 4,001,094,900 | 5,095,231,106 |
| Dividend Yield | 0.0173 | 0.0275 | 0.042 |
| Dividend Payout Ratio | 0.215 | 0.3019 | 0.2624 |
| Debt To Equity Ratio | 1.0719 | 1.0181 | 2.8394 |
| Capital Expenditures | — | — | 230,863,000 |
| Free Cash Flow | — | — | 351,195,000 |
| Return On Equity | 0.0857 | 0.1273 | 0.189 |
| One Year Beta | 0.7454 | 1.1842 | 1.0897 |
| Three Year Beta | 0.9234 | 1.1086 | 1.1388 |
| Five Year Beta | 1.0409 | 1.3883 | 1.3702 |
| Insider Name | Relationship To Issuer | Transaction Date | Amount Of Securities | Acquired Or Disposed | Securities Owned Following Transaction |
|---|---|---|---|---|---|
| Frist William H. | Director | 2026-02-11 | 1,109 | A | 305,172 |
| Malatesta Michael F | CHIEF FINANCIAL OFFICER | 2025-11-01 | 7,357 | D | 238,057 |
| Duggan John F. | Executive Vice President | 2025-11-01 | 4,865 | D | 194,710 |
| Weigl Christopher | CHIEF ACCOUNTING OFFICER | 2025-10-28 | 20,000 | A | 54,254 |
| Frist William H. | Director | 2025-10-28 | 1,266 | A | 304,063 |
| Name Of Reporting Person | Report Date | State | Transaction Type | Transaction Date | Owner Type | Amount |
|---|---|---|---|---|---|---|
| Jim Cooper | 2015-09-17 | TN05 | Sale | 2014-08-06 | — | $1,001 - $15,000 |
| Investor Name | Period Of Report | Market Value | Amount Of Securities | Price Per Security |
|---|---|---|---|---|
| Wealth Preservation Advisors, LLC | 2025-12-31 | 1,598 | 108 | 14.7963 |
| Sunbelt Securities, Inc. | 2025-12-31 | 2,034 | 137 | 14.8467 |
| T. Rowe Price Investment Management, Inc. | 2025-12-31 | 41,981,000 | 2,826,987 | 14.8501 |
| Invesco Ltd. | 2025-12-31 | 15,177,606 | 1,022,061 | 14.85 |
| Empowered Funds, LLC | 2025-12-31 | 7,007,344 | 471,875 | 14.85 |
| Registrant Name | Period Of Report | Fund Name | Fund Symbol | Amount Of Units | Value In Usd | Percentage Value Compared To Assets |
|---|---|---|---|---|---|---|
| PIMCO Equity Series | 2025-12-31 | PIMCO RAFI Dynamic Multi-Factor U.S. Equity ETF | MFUS | 2,648 | 39,322.8 | 0.0187 |
| Advisor Managed Portfolios | 2025-12-31 | Optimize Strategy Index ETF | OPTZ | 32,900 | 488,565 | 0.2439 |
| RYDEX SERIES FUNDS | 2025-12-31 | Class C | RYCMX | 147 | 2,182.95 | 0.0259 |
| RYDEX SERIES FUNDS | 2025-12-31 | Class A | RYAKX | 147 | 2,182.95 | 0.0259 |
| RYDEX SERIES FUNDS | 2025-12-31 | Class H | RYMKX | 147 | 2,182.95 | 0.0259 |